866-997-4948(US-Canada Toll Free)

Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals Market Report 2017

Published By :

QYResearch

Published Date : Jun 2017

Category :

Pharmaceutical

No. of Pages : 100 Pages

In this report, the Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split Asia-Pacific into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Nuclear Medicine & Radio Pharmaceuticals for these regions, from 2012 to 2022 (forecast), including
China
Japan
South Korea
Taiwan
India
Southeast Asia
Australia

Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals market competition by top manufacturers/players, with Nuclear Medicine & Radio Pharmaceuticals sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
GE Healthcare
Philips Healthcare
Siemens Healthcare
Toshiba
Hitachi
Carestream
Esaote
Shimadzu
TriFoil Imaging
Biosensors International Group, Ltd

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals
Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Nuclear Medicine & Radio Pharmaceuticals for each application, includin
Diagnostic Applications: SPECT, PET.
Therapeutic Applications: Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Therapeutic Applications.

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals Market Report 2017
1 Nuclear Medicine & Radio Pharmaceuticals Overview
1.1 Product Overview and Scope of Nuclear Medicine & Radio Pharmaceuticals
1.2 Classification of Nuclear Medicine & Radio Pharmaceuticals by Product Category
1.2.1 Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals Market Size (Sales) Comparison by Types (2012-2022)
1.2.2 Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals
1.2.4 Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes
1.3 Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals Market by Application/End Users
1.3.1 Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals Sales (Volume) and Market Share Comparison by Applications (2012-2022)
1.3.2 Diagnostic Applications: SPECT, PET.
1.3.3 Therapeutic Applications: Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Therapeutic Applications.
1.4 Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals Market by Region
1.4.1 Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals Market Size (Value) Comparison by Region (2012-2022)
1.4.2 China Status and Prospect (2012-2022)
1.4.3 Japan Status and Prospect (2012-2022)
1.4.4 South Korea Status and Prospect (2012-2022)
1.4.5 Taiwan Status and Prospect (2012-2022)
1.4.6 India Status and Prospect (2012-2022)
1.4.7 Southeast Asia Status and Prospect (2012-2022)
1.4.8 Australia Status and Prospect (2012-2022)
1.5 Asia-Pacific Market Size (Value and Volume) of Nuclear Medicine & Radio Pharmaceuticals (2012-2022)
1.5.1 Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2012-2022)
1.5.2 Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals Revenue and Growth Rate (2012-2022)

2 Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals Competition by Players/Suppliers, Region, Type and Application
2.1 Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals Market Competition by Players/Suppliers
2.1.1 Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals Sales Volume and Market Share of Key Players/Suppliers (2012-2017)
2.1.2 Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals Revenue and Share by Players/Suppliers (2012-2017)
2.2 Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals (Volume and Value) by Type
2.2.1 Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals Sales and Market Share by Type (2012-2017)
2.2.2 Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals Revenue and Market Share by Type (2012-2017)
2.3 Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals (Volume) by Application
2.4 Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals (Volume and Value) by Region
2.4.1 Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals Sales and Market Share by Region (2012-2017)
2.4.2 Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals Revenue and Market Share by Region (2012-2017)

3 China Nuclear Medicine & Radio Pharmaceuticals (Volume, Value and Sales Price)
3.1 China Nuclear Medicine & Radio Pharmaceuticals Sales and Value (2012-2017)
3.1.1 China Nuclear Medicine & Radio Pharmaceuticals Sales Volume and Growth Rate (2012-2017)
3.1.2 China Nuclear Medicine & Radio Pharmaceuticals Revenue and Growth Rate (2012-2017)
3.1.3 China Nuclear Medicine & Radio Pharmaceuticals Sales Price Trend (2012-2017)
3.2 China Nuclear Medicine & Radio Pharmaceuticals Sales Volume and Market Share by Type
3.3 China Nuclear Medicine & Radio Pharmaceuticals Sales Volume and Market Share by Application

4 Japan Nuclear Medicine & Radio Pharmaceuticals (Volume, Value and Sales Price)
4.1 Japan Nuclear Medicine & Radio Pharmaceuticals Sales and Value (2012-2017)
4.1.1 Japan Nuclear Medicine & Radio Pharmaceuticals Sales Volume and Growth Rate (2012-2017)
4.1.2 Japan Nuclear Medicine & Radio Pharmaceuticals Revenue and Growth Rate (2012-2017)
4.1.3 Japan Nuclear Medicine & Radio Pharmaceuticals Sales Price Trend (2012-2017)
4.2 Japan Nuclear Medicine & Radio Pharmaceuticals Sales Volume and Market Share by Type
4.3 Japan Nuclear Medicine & Radio Pharmaceuticals Sales Volume and Market Share by Application

5 South Korea Nuclear Medicine & Radio Pharmaceuticals (Volume, Value and Sales Price)
5.1 South Korea Nuclear Medicine & Radio Pharmaceuticals Sales and Value (2012-2017)
5.1.1 South Korea Nuclear Medicine & Radio Pharmaceuticals Sales Volume and Growth Rate (2012-2017)
5.1.2 South Korea Nuclear Medicine & Radio Pharmaceuticals Revenue and Growth Rate (2012-2017)
5.1.3 South Korea Nuclear Medicine & Radio Pharmaceuticals Sales Price Trend (2012-2017)
5.2 South Korea Nuclear Medicine & Radio Pharmaceuticals Sales Volume and Market Share by Type
5.3 South Korea Nuclear Medicine & Radio Pharmaceuticals Sales Volume and Market Share by Application

6 Taiwan Nuclear Medicine & Radio Pharmaceuticals (Volume, Value and Sales Price)
6.1 Taiwan Nuclear Medicine & Radio Pharmaceuticals Sales and Value (2012-2017)
6.1.1 Taiwan Nuclear Medicine & Radio Pharmaceuticals Sales Volume and Growth Rate (2012-2017)
6.1.2 Taiwan Nuclear Medicine & Radio Pharmaceuticals Revenue and Growth Rate (2012-2017)
6.1.3 Taiwan Nuclear Medicine & Radio Pharmaceuticals Sales Price Trend (2012-2017)
6.2 Taiwan Nuclear Medicine & Radio Pharmaceuticals Sales Volume and Market Share by Type
6.3 Taiwan Nuclear Medicine & Radio Pharmaceuticals Sales Volume and Market Share by Application

7 India Nuclear Medicine & Radio Pharmaceuticals (Volume, Value and Sales Price)
7.1 India Nuclear Medicine & Radio Pharmaceuticals Sales and Value (2012-2017)
7.1.1 India Nuclear Medicine & Radio Pharmaceuticals Sales Volume and Growth Rate (2012-2017)
7.1.2 India Nuclear Medicine & Radio Pharmaceuticals Revenue and Growth Rate (2012-2017)
7.1.3 India Nuclear Medicine & Radio Pharmaceuticals Sales Price Trend (2012-2017)
7.2 India Nuclear Medicine & Radio Pharmaceuticals Sales Volume and Market Share by Type
7.3 India Nuclear Medicine & Radio Pharmaceuticals Sales Volume and Market Share by Application

8 Southeast Asia Nuclear Medicine & Radio Pharmaceuticals (Volume, Value and Sales Price)
8.1 Southeast Asia Nuclear Medicine & Radio Pharmaceuticals Sales and Value (2012-2017)
8.1.1 Southeast Asia Nuclear Medicine & Radio Pharmaceuticals Sales Volume and Growth Rate (2012-2017)
8.1.2 Southeast Asia Nuclear Medicine & Radio Pharmaceuticals Revenue and Growth Rate (2012-2017)
8.1.3 Southeast Asia Nuclear Medicine & Radio Pharmaceuticals Sales Price Trend (2012-2017)
8.2 Southeast Asia Nuclear Medicine & Radio Pharmaceuticals Sales Volume and Market Share by Type
8.3 Southeast Asia Nuclear Medicine & Radio Pharmaceuticals Sales Volume and Market Share by Application

9 Australia Nuclear Medicine & Radio Pharmaceuticals (Volume, Value and Sales Price)
9.1 Australia Nuclear Medicine & Radio Pharmaceuticals Sales and Value (2012-2017)
9.1.1 Australia Nuclear Medicine & Radio Pharmaceuticals Sales Volume and Growth Rate (2012-2017)
9.1.2 Australia Nuclear Medicine & Radio Pharmaceuticals Revenue and Growth Rate (2012-2017)
9.1.3 Australia Nuclear Medicine & Radio Pharmaceuticals Sales Price Trend (2012-2017)
9.2 Australia Nuclear Medicine & Radio Pharmaceuticals Sales Volume and Market Share by Type
9.3 Australia Nuclear Medicine & Radio Pharmaceuticals Sales Volume and Market Share by Application

10 Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals Players/Suppliers Profiles and Sales Data
10.1 GE Healthcare
10.1.1 Company Basic Information, Manufacturing Base and Competitors
10.1.2 Nuclear Medicine & Radio Pharmaceuticals Product Category, Application and Specification
10.1.2.1 Product A
10.1.2.2 Product B
10.1.3 GE Healthcare Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
10.1.4 Main Business/Business Overview
10.2 Philips Healthcare
10.2.1 Company Basic Information, Manufacturing Base and Competitors
10.2.2 Nuclear Medicine & Radio Pharmaceuticals Product Category, Application and Specification
10.2.2.1 Product A
10.2.2.2 Product B
10.2.3 Philips Healthcare Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
10.2.4 Main Business/Business Overview
10.3 Siemens Healthcare
10.3.1 Company Basic Information, Manufacturing Base and Competitors
10.3.2 Nuclear Medicine & Radio Pharmaceuticals Product Category, Application and Specification
10.3.2.1 Product A
10.3.2.2 Product B
10.3.3 Siemens Healthcare Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
10.3.4 Main Business/Business Overview
10.4 Toshiba
10.4.1 Company Basic Information, Manufacturing Base and Competitors
10.4.2 Nuclear Medicine & Radio Pharmaceuticals Product Category, Application and Specification
10.4.2.1 Product A
10.4.2.2 Product B
10.4.3 Toshiba Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
10.4.4 Main Business/Business Overview
10.5 Hitachi
10.5.1 Company Basic Information, Manufacturing Base and Competitors
10.5.2 Nuclear Medicine & Radio Pharmaceuticals Product Category, Application and Specification
10.5.2.1 Product A
10.5.2.2 Product B
10.5.3 Hitachi Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
10.5.4 Main Business/Business Overview
10.6 Carestream
10.6.1 Company Basic Information, Manufacturing Base and Competitors
10.6.2 Nuclear Medicine & Radio Pharmaceuticals Product Category, Application and Specification
10.6.2.1 Product A
10.6.2.2 Product B
10.6.3 Carestream Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
10.6.4 Main Business/Business Overview
10.7 Esaote
10.7.1 Company Basic Information, Manufacturing Base and Competitors
10.7.2 Nuclear Medicine & Radio Pharmaceuticals Product Category, Application and Specification
10.7.2.1 Product A
10.7.2.2 Product B
10.7.3 Esaote Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
10.7.4 Main Business/Business Overview
10.8 Shimadzu
10.8.1 Company Basic Information, Manufacturing Base and Competitors
10.8.2 Nuclear Medicine & Radio Pharmaceuticals Product Category, Application and Specification
10.8.2.1 Product A
10.8.2.2 Product B
10.8.3 Shimadzu Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
10.8.4 Main Business/Business Overview
10.9 TriFoil Imaging
10.9.1 Company Basic Information, Manufacturing Base and Competitors
10.9.2 Nuclear Medicine & Radio Pharmaceuticals Product Category, Application and Specification
10.9.2.1 Product A
10.9.2.2 Product B
10.9.3 TriFoil Imaging Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
10.9.4 Main Business/Business Overview
10.10 Biosensors International Group, Ltd
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Nuclear Medicine & Radio Pharmaceuticals Product Category, Application and Specification
10.10.2.1 Product A
10.10.2.2 Product B
10.10.3 Biosensors International Group, Ltd Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
10.10.4 Main Business/Business Overview

11 Nuclear Medicine & Radio Pharmaceuticals Manufacturing Cost Analysis
11.1 Nuclear Medicine & Radio Pharmaceuticals Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.1.2 Price Trend of Key Raw Materials
11.1.3 Key Suppliers of Raw Materials
11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Nuclear Medicine & Radio Pharmaceuticals

12 Industrial Chain, Sourcing Strategy and Downstream Buyers
12.1 Nuclear Medicine & Radio Pharmaceuticals Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Nuclear Medicine & Radio Pharmaceuticals Major Manufacturers in 2016
12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders
13.1 Marketing Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
13.2.1 Pricing Strategy
13.2.2 Brand Strategy
13.2.3 Target Client
13.3 Distributors/Traders List

14 Market Effect Factors Analysis
14.1 Technology Progress/Risk
14.1.1 Substitutes Threat
14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals Market Forecast (2017-2022)
15.1 Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals Sales Volume, Revenue and Price Forecast (2017-2022)
15.1.1 Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals Sales Volume and Growth Rate Forecast (2017-2022)
15.1.2 Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals Revenue and Growth Rate Forecast (2017-2022)
15.1.3 Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals Price and Trend Forecast (2017-2022)
15.2 Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
15.2.1 Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals Sales Volume and Growth Rate Forecast by Region (2017-2022)
15.2.2 Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals Revenue and Growth Rate Forecast by Region (2017-2022)
15.2.3 China Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.4 Japan Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.5 South Korea Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.6 Taiwan Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.7 India Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.8 Southeast Asia Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.9 Australia Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue and Growth Rate Forecast (2017-2022)
15.3 Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue and Price Forecast by Type (2017-2022)
15.3.1 Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals Sales Forecast by Type (2017-2022)
15.3.2 Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals Revenue Forecast by Type (2017-2022)
15.3.3 Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals Price Forecast by Type (2017-2022)
15.4 Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals Sales Forecast by Application (2017-2022)

16 Research Findings and Conclusion

17 Appendix
17.1 Methodology/Research Approach
17.1.1 Research Programs/Design
17.1.2 Market Size Estimation
17.1.3 Market Breakdown and Data Triangulation
17.2 Data Source
17.2.1 Secondary Sources
17.2.2 Primary Sources
17.3 Disclaimer


List of Table

List of Tables and Figures

Figure Product Picture of Nuclear Medicine & Radio Pharmaceuticals
Figure Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals Sales Volume (K Units) by Type (2012-2022)
Figure Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals Sales Volume Market Share by Type (Product Category) in 2016
Figure Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals Product Picture
Figure Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes Product Picture
Figure Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals Sales (K Units) by Application (2012-2022)
Figure Asia-Pacific Sales Market Share of Nuclear Medicine & Radio Pharmaceuticals by Application in 2016
Figure Diagnostic Applications: SPECT, PET. Examples
Figure Therapeutic Applications: Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Therapeutic Applications. Examples
Figure Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals Market Size (Million USD) by Region (2012-2022)
Figure China Nuclear Medicine & Radio Pharmaceuticals Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Nuclear Medicine & Radio Pharmaceuticals Revenue (Million USD) and Growth Rate (2012-2022)
Figure South Korea Nuclear Medicine & Radio Pharmaceuticals Revenue (Million USD) and Growth Rate (2012-2022)
Figure Taiwan Nuclear Medicine & Radio Pharmaceuticals Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Nuclear Medicine & Radio Pharmaceuticals Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Nuclear Medicine & Radio Pharmaceuticals Revenue (Million USD) and Growth Rate (2012-2022)
Figure Australia Nuclear Medicine & Radio Pharmaceuticals Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals Sales Volume (K Units) and Growth Rate (2012-2022)
Figure Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals Market Major Players Product Sales Volume (K Units)(2012-2017)
Table Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals Sales (K Units) of Key Players/Suppliers (2012-2017)
Table Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals Sales Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals Sales Share by Players/Suppliers
Figure 2017 Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals Sales Share by Players/Suppliers
Figure Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals Market Major Players Product Revenue (Million USD) 2012-2017
Table Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals Revenue Share by Players
Figure 2017 Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals Revenue Share by Players
Table Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals Sales and Market Share by Type (2012-2017)
Table Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals Sales Share by Type (2012-2017)
Figure Sales Market Share of Nuclear Medicine & Radio Pharmaceuticals by Type (2012-2017)
Figure Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals Sales Growth Rate by Type (2012-2017)
Table Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals Revenue (Million USD) and Market Share by Type (2012-2017)
Table Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Nuclear Medicine & Radio Pharmaceuticals by Type (2012-2017)
Figure Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals Revenue Growth Rate by Type (2012-2017)
Table Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals Sales Volume (K Units) and Market Share by Region (2012-2017)
Table Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals Sales Share by Region (2012-2017)
Figure Sales Market Share of Nuclear Medicine & Radio Pharmaceuticals by Region (2012-2017)
Figure Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Region in 2016
Table Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals Revenue (Million USD) and Market Share by Region (2012-2017)
Table Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Nuclear Medicine & Radio Pharmaceuticals by Region (2012-2017)
Figure Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share by Region in 2016
Table Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals Sales Volume (K Units) and Market Share by Application (2012-2017)
Table Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals Sales Share (%) by Application (2012-2017)
Figure Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Application (2012-2017)
Figure Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Application (2012-2017)
Figure China Nuclear Medicine & Radio Pharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure China Nuclear Medicine & Radio Pharmaceuticals Revenue (Million USD) and Growth Rate (2012-2017)
Figure China Nuclear Medicine & Radio Pharmaceuticals Sales Price (USD/Unit) Trend (2012-2017)
Table China Nuclear Medicine & Radio Pharmaceuticals Sales Volume (K Units) by Type (2012-2017)
Table China Nuclear Medicine & Radio Pharmaceuticals Sales Volume Market Share by Type (2012-2017)
Figure China Nuclear Medicine & Radio Pharmaceuticals Sales Volume Market Share by Type in 2016
Table China Nuclear Medicine & Radio Pharmaceuticals Sales Volume (K Units) by Applications (2012-2017)
Table China Nuclear Medicine & Radio Pharmaceuticals Sales Volume Market Share by Application (2012-2017)
Figure China Nuclear Medicine & Radio Pharmaceuticals Sales Volume Market Share by Application in 2016
Figure Japan Nuclear Medicine & Radio Pharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure Japan Nuclear Medicine & Radio Pharmaceuticals Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan Nuclear Medicine & Radio Pharmaceuticals Sales Price (USD/Unit) Trend (2012-2017)
Table Japan Nuclear Medicine & Radio Pharmaceuticals Sales Volume (K Units) by Type (2012-2017)
Table Japan Nuclear Medicine & Radio Pharmaceuticals Sales Volume Market Share by Type (2012-2017)
Figure Japan Nuclear Medicine & Radio Pharmaceuticals Sales Volume Market Share by Type in 2016
Table Japan Nuclear Medicine & Radio Pharmaceuticals Sales Volume (K Units) by Applications (2012-2017)
Table Japan Nuclear Medicine & Radio Pharmaceuticals Sales Volume Market Share by Application (2012-2017)
Figure Japan Nuclear Medicine & Radio Pharmaceuticals Sales Volume Market Share by Application in 2016
Figure South Korea Nuclear Medicine & Radio Pharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure South Korea Nuclear Medicine & Radio Pharmaceuticals Revenue (Million USD) and Growth Rate (2012-2017)
Figure South Korea Nuclear Medicine & Radio Pharmaceuticals Sales Price (USD/Unit) Trend (2012-2017)
Table South Korea Nuclear Medicine & Radio Pharmaceuticals Sales Volume (K Units) by Type (2012-2017)
Table South Korea Nuclear Medicine & Radio Pharmaceuticals Sales Volume Market Share by Type (2012-2017)
Figure South Korea Nuclear Medicine & Radio Pharmaceuticals Sales Volume Market Share by Type in 2016
Table South Korea Nuclear Medicine & Radio Pharmaceuticals Sales Volume (K Units) by Applications (2012-2017)
Table South Korea Nuclear Medicine & Radio Pharmaceuticals Sales Volume Market Share by Application (2012-2017)
Figure South Korea Nuclear Medicine & Radio Pharmaceuticals Sales Volume Market Share by Application in 2016
Figure Taiwan Nuclear Medicine & Radio Pharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure Taiwan Nuclear Medicine & Radio Pharmaceuticals Revenue (Million USD) and Growth Rate (2012-2017)
Figure Taiwan Nuclear Medicine & Radio Pharmaceuticals Sales Price (USD/Unit) Trend (2012-2017)
Table Taiwan Nuclear Medicine & Radio Pharmaceuticals Sales Volume (K Units) by Type (2012-2017)
Table Taiwan Nuclear Medicine & Radio Pharmaceuticals Sales Volume Market Share by Type (2012-2017)
Figure Taiwan Nuclear Medicine & Radio Pharmaceuticals Sales Volume Market Share by Type in 2016
Table Taiwan Nuclear Medicine & Radio Pharmaceuticals Sales Volume (K Units) by Applications (2012-2017)
Table Taiwan Nuclear Medicine & Radio Pharmaceuticals Sales Volume Market Share by Application (2012-2017)
Figure Taiwan Nuclear Medicine & Radio Pharmaceuticals Sales Volume Market Share by Application in 2016
Figure India Nuclear Medicine & Radio Pharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure India Nuclear Medicine & Radio Pharmaceuticals Revenue (Million USD) and Growth Rate (2012-2017)
Figure India Nuclear Medicine & Radio Pharmaceuticals Sales Price (USD/Unit) Trend (2012-2017)
Table India Nuclear Medicine & Radio Pharmaceuticals Sales Volume (K Units) by Type (2012-2017)
Table India Nuclear Medicine & Radio Pharmaceuticals Sales Volume Market Share by Type (2012-2017)
Figure India Nuclear Medicine & Radio Pharmaceuticals Sales Volume Market Share by Type in 2016
Table India Nuclear Medicine & Radio Pharmaceuticals Sales Volume (K Units) by Application (2012-2017)
Table India Nuclear Medicine & Radio Pharmaceuticals Sales Volume Market Share by Application (2012-2017)
Figure India Nuclear Medicine & Radio Pharmaceuticals Sales Volume Market Share by Application in 2016
Figure Southeast Asia Nuclear Medicine & Radio Pharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure Southeast Asia Nuclear Medicine & Radio Pharmaceuticals Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia Nuclear Medicine & Radio Pharmaceuticals Sales Price (USD/Unit) Trend (2012-2017)
Table Southeast Asia Nuclear Medicine & Radio Pharmaceuticals Sales Volume (K Units) by Type (2012-2017)
Table Southeast Asia Nuclear Medicine & Radio Pharmaceuticals Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia Nuclear Medicine & Radio Pharmaceuticals Sales Volume Market Share by Type in 2016
Table Southeast Asia Nuclear Medicine & Radio Pharmaceuticals Sales Volume (K Units) by Applications (2012-2017)
Table Southeast Asia Nuclear Medicine & Radio Pharmaceuticals Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia Nuclear Medicine & Radio Pharmaceuticals Sales Volume Market Share by Application in 2016
Figure Australia Nuclear Medicine & Radio Pharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure Australia Nuclear Medicine & Radio Pharmaceuticals Revenue (Million USD) and Growth Rate (2012-2017)
Figure Australia Nuclear Medicine & Radio Pharmaceuticals Sales Price (USD/Unit) Trend (2012-2017)
Table Australia Nuclear Medicine & Radio Pharmaceuticals Sales Volume (K Units) by Type (2012-2017)
Table Australia Nuclear Medicine & Radio Pharmaceuticals Sales Volume Market Share by Type (2012-2017)
Figure Australia Nuclear Medicine & Radio Pharmaceuticals Sales Volume Market Share by Type in 2016
Table Australia Nuclear Medicine & Radio Pharmaceuticals Sales Volume (K Units) by Applications (2012-2017)
Table Australia Nuclear Medicine & Radio Pharmaceuticals Sales Volume Market Share by Application (2012-2017)
Figure Australia Nuclear Medicine & Radio Pharmaceuticals Sales Volume Market Share by Application in 2016
Table GE Healthcare Nuclear Medicine & Radio Pharmaceuticals Basic Information List
Table GE Healthcare Nuclear Medicine & Radio Pharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GE Healthcare Nuclear Medicine & Radio Pharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure GE Healthcare Nuclear Medicine & Radio Pharmaceuticals Sales Market Share in Asia-Pacific (2012-2017)
Figure GE Healthcare Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share in Asia-Pacific (2012-2017)
Table Philips Healthcare Nuclear Medicine & Radio Pharmaceuticals Basic Information List
Table Philips Healthcare Nuclear Medicine & Radio Pharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Philips Healthcare Nuclear Medicine & Radio Pharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure Philips Healthcare Nuclear Medicine & Radio Pharmaceuticals Sales Market Share in Asia-Pacific (2012-2017)
Figure Philips Healthcare Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share in Asia-Pacific (2012-2017)
Table Siemens Healthcare Nuclear Medicine & Radio Pharmaceuticals Basic Information List
Table Siemens Healthcare Nuclear Medicine & Radio Pharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Siemens Healthcare Nuclear Medicine & Radio Pharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure Siemens Healthcare Nuclear Medicine & Radio Pharmaceuticals Sales Market Share in Asia-Pacific (2012-2017)
Figure Siemens Healthcare Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share in Asia-Pacific (2012-2017)
Table Toshiba Nuclear Medicine & Radio Pharmaceuticals Basic Information List
Table Toshiba Nuclear Medicine & Radio Pharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Toshiba Nuclear Medicine & Radio Pharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure Toshiba Nuclear Medicine & Radio Pharmaceuticals Sales Market Share in Asia-Pacific (2012-2017)
Figure Toshiba Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share in Asia-Pacific (2012-2017)
Table Hitachi Nuclear Medicine & Radio Pharmaceuticals Basic Information List
Table Hitachi Nuclear Medicine & Radio Pharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Hitachi Nuclear Medicine & Radio Pharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure Hitachi Nuclear Medicine & Radio Pharmaceuticals Sales Market Share in Asia-Pacific (2012-2017)
Figure Hitachi Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share in Asia-Pacific (2012-2017)
Table Carestream Nuclear Medicine & Radio Pharmaceuticals Basic Information List
Table Carestream Nuclear Medicine & Radio Pharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Carestream Nuclear Medicine & Radio Pharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure Carestream Nuclear Medicine & Radio Pharmaceuticals Sales Market Share in Asia-Pacific (2012-2017)
Figure Carestream Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share in Asia-Pacific (2012-2017)
Table Esaote Nuclear Medicine & Radio Pharmaceuticals Basic Information List
Table Esaote Nuclear Medicine & Radio Pharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Esaote Nuclear Medicine & Radio Pharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure Esaote Nuclear Medicine & Radio Pharmaceuticals Sales Market Share in Asia-Pacific (2012-2017)
Figure Esaote Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share in Asia-Pacific (2012-2017)
Table Shimadzu Nuclear Medicine & Radio Pharmaceuticals Basic Information List
Table Shimadzu Nuclear Medicine & Radio Pharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Shimadzu Nuclear Medicine & Radio Pharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure Shimadzu Nuclear Medicine & Radio Pharmaceuticals Sales Market Share in Asia-Pacific (2012-2017)
Figure Shimadzu Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share in Asia-Pacific (2012-2017)
Table TriFoil Imaging Nuclear Medicine & Radio Pharmaceuticals Basic Information List
Table TriFoil Imaging Nuclear Medicine & Radio Pharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure TriFoil Imaging Nuclear Medicine & Radio Pharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure TriFoil Imaging Nuclear Medicine & Radio Pharmaceuticals Sales Market Share in Asia-Pacific (2012-2017)
Figure TriFoil Imaging Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share in Asia-Pacific (2012-2017)
Table Biosensors International Group, Ltd Nuclear Medicine & Radio Pharmaceuticals Basic Information List
Table Biosensors International Group, Ltd Nuclear Medicine & Radio Pharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Biosensors International Group, Ltd Nuclear Medicine & Radio Pharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure Biosensors International Group, Ltd Nuclear Medicine & Radio Pharmaceuticals Sales Market Share in Asia-Pacific (2012-2017)
Figure Biosensors International Group, Ltd Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share in Asia-Pacific (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price (USD/Unit) Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Nuclear Medicine & Radio Pharmaceuticals
Figure Manufacturing Process Analysis of Nuclear Medicine & Radio Pharmaceuticals
Figure Nuclear Medicine & Radio Pharmaceuticals Industrial Chain Analysis
Table Raw Materials Sources of Nuclear Medicine & Radio Pharmaceuticals Major Manufacturers in 2016
Table Major Buyers of Nuclear Medicine & Radio Pharmaceuticals
Table Distributors/Traders List
Figure Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals Price (USD/Unit) and Trend Forecast (2017-2022)
Table Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals Sales Volume (K Units) Forecast by Region (2017-2022)
Figure Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals Sales Volume Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals Sales Volume Market Share Forecast by Region in 2022
Table Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals Revenue (Million USD) Forecast by Region (2017-2022)
Figure Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share Forecast by Region in 2022
Figure China Nuclear Medicine & Radio Pharmaceuticals Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure China Nuclear Medicine & Radio Pharmaceuticals Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan Nuclear Medicine & Radio Pharmaceuticals Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure Japan Nuclear Medicine & Radio Pharmaceuticals Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure South Korea Nuclear Medicine & Radio Pharmaceuticals Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure South Korea Nuclear Medicine & Radio Pharmaceuticals Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Taiwan Nuclear Medicine & Radio Pharmaceuticals Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure Taiwan Nuclear Medicine & Radio Pharmaceuticals Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India Nuclear Medicine & Radio Pharmaceuticals Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure India Nuclear Medicine & Radio Pharmaceuticals Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Nuclear Medicine & Radio Pharmaceuticals Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Nuclear Medicine & Radio Pharmaceuticals Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Australia Nuclear Medicine & Radio Pharmaceuticals Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure Australia Nuclear Medicine & Radio Pharmaceuticals Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals Sales (K Units) Forecast by Type (2017-2022)
Figure Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals Sales Market Share Forecast by Type (2017-2022)
Table Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals Revenue (Million USD) Forecast by Type (2017-2022)
Figure Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share Forecast by Type (2017-2022)
Table Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals Price (USD/Unit) Forecast by Type (2017-2022)
Table Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals Sales (K Units) Forecast by Application (2017-2022)
Figure Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *